Phase 3 ASPIRE trial and monoclonal antibodies for treating multiple myeloma

At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Keith Stewart (Mayo Clinic, Scottsdale, AZ) discusses the phase 3 ASPIRE trial comparing carfilzomib, lenalidomide, and dexamethas... Author: VJHemOnc Added: 04/28/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts